¥2,505.50
0.04%
Tokyo, Oct 10, 08:15 am CET
ISIN
JP3546800008
Symbol
4543
Index

Terumo Stock price

¥2,494.50
-95.50 3.69% 1M
-365.00 12.76% 6M
-567.50 18.53% YTD
-449.00 15.25% 1Y
+325.00 14.98% 3Y
+442.00 21.53% 5Y
+1,655.75 197.41% 10Y
+2,067.00 483.51% 20Y
Tokyo, Closing price Fri, Oct 10 2025
-12.00 0.48%
ISIN
JP3546800008
Symbol
4543
Index

Key metrics

Basic
Market capitalization
¥3.7t
Enterprise Value
¥3.7t
Net debt
positive
Cash
¥204.4b
Shares outstanding
1.5b
Valuation (TTM | estimate)
P/E
29.5 | 24.4
P/S
3.6 | 3.4
EV/Sales
3.5 | 3.4
EV/FCF
29.6
P/B
2.7
Dividends
DPS
¥30.00
Yield 1Y | 5Y
1.2% | 1.0%
Growth 1Y | 5Y
15.4% | 15.7%
Payout 1Y | 3Y
32.9% | 32.4%
Increased
7 Years
Financials (TTM | estimate)
Revenue
¥1.0t | ¥1.1t
EBITDA
¥254.5b | ¥285.7b
EBIT
¥168.9b | ¥191.9b
Net Income
¥124.9b | ¥150.9b
Free Cash Flow
¥123.9b
Growth (TTM | estimate)
Revenue
7.6% | 4.4%
EBITDA
8.4% | 36.7%
EBIT
8.9% | 5.9%
Net Income
6.1% | 29.0%
Free Cash Flow
34.5%
Margin (TTM | estimate)
Gross
54.8%
EBITDA
24.5% | 26.4%
EBIT
16.3%
Net
12.0% | 14.0%
Free Cash Flow
11.9%
Financial Health
Equity Ratio
74.9%
Return on Equity
8.6%
ROCE
11.1%
ROIC
9.1%
Debt/Equity
0.1
More
EPS
¥84.7
FCF per Share
¥84.0
Short interest
-
Employees
28k
Rev per Employee
¥36.6m
Show more

Is Terumo a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,999 stocks worldwide.

Terumo Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Terumo forecast:

16x Buy
76%
5x Hold
24%

Analyst Opinions

21 Analysts have issued a Terumo forecast:

Buy
76%
Hold
24%

Financial data from Terumo

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
1,037,942 1,037,942
8% 8%
100%
- Direct Costs 469,375 469,375
3% 3%
45%
568,567 568,567
12% 12%
55%
- Selling and Administrative Expenses 381,472 381,472
7% 7%
37%
- Research and Development Expense - -
-
-
254,542 254,542
8% 8%
25%
- Depreciation and Amortization 85,629 85,629
7% 7%
8%
EBIT (Operating Income) EBIT 168,913 168,913
9% 9%
16%
Net Profit 124,930 124,930
6% 6%
12%

In millions JPY.

Don't miss a Thing! We will send you all news about Terumo directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan

Head office Japan
CEO Hikaru Samejima
Employees 28,294
Founded 1921
Website www.terumo.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today